CAPECITABINE, CAPECITABINE, NUBEQA 300 mg film-coated tablets
UC-0140/1711_UCBG3
Phase 2 small_molecule active
Quick answer
CAPECITABINE, CAPECITABINE, NUBEQA 300 mg film-coated tablets for Triple-negative androgen receptor positive (molecular apocrine-like HER2-negative subtype) locally recurrent (unresectable) or metastatic breast cancer. is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Triple-negative androgen receptor positive (molecular apocrine-like HER2-negative subtype) locally recurrent (unresectable) or metastatic breast cancer.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active